| http://dbpedia.org/ontology/abstract
|
4-Propionoxy-N,N-dimethyltryptamine (4-PrO … 4-Propionoxy-N,N-dimethyltryptamine (4-PrO-DMT, or O-Propionylpsilocin) is a synthetic psychedelic drug from the tryptamine family with psychedelic effects, and is theorized to act as a prodrug for psilocin. It has been sold online as a designer drug since May 2019. It was first identified as a new psychoactive substance in Sweden, in July 2019.oactive substance in Sweden, in July 2019.
|
| http://dbpedia.org/ontology/casNumber
|
1373882-11-1
|
| http://dbpedia.org/ontology/fdaUniiCode
|
B9BF25HPH4
|
| http://dbpedia.org/ontology/pubchem
|
155907598
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/4-PrO-DMT.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
67977435
|
| http://dbpedia.org/ontology/wikiPageLength
|
3295
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1107989646
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Prodrug +
, http://dbpedia.org/resource/5-MeO-DMT +
, http://dbpedia.org/resource/Category:Esters +
, http://dbpedia.org/resource/Psychedelic +
, http://dbpedia.org/resource/5-HT_receptor +
, http://dbpedia.org/resource/Psilocin +
, http://dbpedia.org/resource/4-HO-DMT +
, http://dbpedia.org/resource/4-AcO-DMT +
, http://dbpedia.org/resource/Tryptamine +
, http://dbpedia.org/resource/Category:Psychedelic_tryptamines +
, http://dbpedia.org/resource/File:4-Propionoxy-N%2CN-dimethyltryptamine.jpg +
, http://dbpedia.org/resource/Pro-drug +
, http://dbpedia.org/resource/Psilocybin +
, http://dbpedia.org/resource/Partial_agonist +
, http://dbpedia.org/resource/Category:Prodrugs +
, http://dbpedia.org/resource/Category:Entheogens +
, http://dbpedia.org/resource/Psilacetin +
, http://dbpedia.org/resource/5-HT1B_receptor +
, http://dbpedia.org/resource/5-HT1D_receptor +
, http://dbpedia.org/resource/Designer_drug +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:Dimethylamino_compounds +
, http://dbpedia.org/resource/Serotonergic +
, http://dbpedia.org/resource/LSD +
, http://dbpedia.org/resource/Psychedelic_drug +
, http://dbpedia.org/resource/5-HT1A_receptor +
, http://dbpedia.org/resource/Category:Serotonin_receptor_agonists +
|
| http://dbpedia.org/property/c
|
15
|
| http://dbpedia.org/property/casNumber
|
1373882
|
| http://dbpedia.org/property/chemspiderid
|
84400449
|
| http://dbpedia.org/property/drugName
|
4
|
| http://dbpedia.org/property/h
|
20
|
| http://dbpedia.org/property/image
|
4
|
| http://dbpedia.org/property/iupacName
|
[3-[2-ethyl]-1H-indol-4-yl] propanoate
|
| http://dbpedia.org/property/n
|
2
|
| http://dbpedia.org/property/o
|
2
|
| http://dbpedia.org/property/pubchem
|
155907598
|
| http://dbpedia.org/property/smiles
|
CCCOC1=CC=CC2=C1CCCNC
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
KUOGXPDQORRHED-UHFFFAOYSA-N
|
| http://dbpedia.org/property/synonyms
|
4
|
| http://dbpedia.org/property/unii
|
B9BF25HPH4
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Unreferenced_section +
, http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Tryptamines +
, http://dbpedia.org/resource/Template:Citation_needed +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Serotonergics +
, http://dbpedia.org/resource/Template:Hallucinogenic_tryptamines +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:Dimethylamino_compounds +
, http://dbpedia.org/resource/Category:Psychedelic_tryptamines +
, http://dbpedia.org/resource/Category:Entheogens +
, http://dbpedia.org/resource/Category:Serotonin_receptor_agonists +
, http://dbpedia.org/resource/Category:Esters +
, http://dbpedia.org/resource/Category:Prodrugs +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/4-PrO-DMT?oldid=1107989646&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/4-PrO-DMT.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/4-PrO-DMT_3D_BS.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/4-Propionoxy-N%2CN-dimethyltryptamine.jpg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/4-PrO-DMT +
|
| http://xmlns.com/foaf/0.1/name
|
4-PrO-DMT
|
| owl:sameAs |
http://www.wikidata.org/entity/Q107303544 +
, https://global.dbpedia.org/id/FpTXJ +
, http://dbpedia.org/resource/4-PrO-DMT +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/Drug +
, http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
|
| rdfs:comment |
4-Propionoxy-N,N-dimethyltryptamine (4-PrO … 4-Propionoxy-N,N-dimethyltryptamine (4-PrO-DMT, or O-Propionylpsilocin) is a synthetic psychedelic drug from the tryptamine family with psychedelic effects, and is theorized to act as a prodrug for psilocin. It has been sold online as a designer drug since May 2019. It was first identified as a new psychoactive substance in Sweden, in July 2019.oactive substance in Sweden, in July 2019.
|
| rdfs:label |
4-PrO-DMT
|
